Background: We attempted to clone candidate genes on 10p14-15 which may regulate hTERT expression, through exon trapping using 3 BAC clones covering the region. After obtaining 20 exons, we examined the function of RGM249 (RGM: RNA gene for miRNAs) we cloned from primary cultured human hepatocytes and hepatoma cell lines. We confirmed approximately 20 bp products digested by Dicer, and investigated the function of this cloned gene and its involvement in hTERT expression by transfecting the hepatoma cell lines with full-length dsRNA, gene-specific designed siRNA, and shRNA-generating plasmid.
Background
Telomerase, which adds repeated telomere sequences to chromosome ends, is a ribonucleoprotein enzyme that includes an endogeneous RNA (hTR) which acts as a template and a reverse transcriptase (hTERT), and are crucial molecules [1] [2] [3] [4] . Telomerase activity has been detected in immortalized and tumor cells and its strong expression represents an important difference between normal and cancer cells [5] . Although it is thought that telomere maintenance is predominantly due to telomerase activity [6, 7] , which is mainly regulated by hTERT expression in the presence of hTR [8, 9] , some gaps exist in the steps between immortalization, carcinogenesis, and cellular senescence [10] . Therefore, these unknown steps must first be fully identified before translational applications are possible [11] [12] [13] . As several reports have indicated that human chromosome 10p carries a set of genes involved in regulating telomerase activity [14] [15] [16] , we performed microcell-mediated chromosome transfer, radiated microcell fusion, and bacterial artificial chromosome (BAC) transfer assuming loss of heterozygosity (LOH), and examined telomerase expression in transfectants to determine whether hTR-and hTERT-regulating genes are located on 10p15 [17] . After we determined the telomerase regulatory regions on chromosome 10p15.1 using DNA markers, we confirmed that the chromosomal fragments containing the regions induce senescence in the transfectants [18, 19] . We then identified that radiated chromosomal fragments containing D10S1728 (a genomic region on chromosome 10p15) induced senescence in transfectants, and performed the sequencing of 3 BAC clones containing D10S1728 [20] [21] [22] (data not shown), exon trapping using the BAC clones [23] [24] [25] , Northern blotting, and RT-PCR before cloning several full-length genes. One of the genes we cloned was named RGM249 (RNA gene for miRNAs which was 249 bp in length), and showed stronger gene expression in cancerous lesions than in normal liver.
We used the RNA interference (RNAi) method, which is a sequence-specific post-transcriptional gene silencing mechanism triggered by double-stranded RNA (dsRNA), to cause degradation of mRNAs homologous in sequence to dsRNA and to effectively inhibit genespecific expression [26] . Because dsRNA transfection is a common strategy for suppressing genes of interest, the small interfering RNA (siRNA) technique is an excellent gene-specific method for determining the function of the targeted gene by inhibiting its expression [27] [28] [29] [30] . After focusing on RGM249 (RGM: RNA gene for miRNAs; 249 for 249 bp) among the genes cloned on 10p14-15 for further analyses, we examined the telomerase regulatory function of RGM249 using the overexpressing cassette and the gene-specific siRNA.
In this report, we present a summary of our cloning research and introduce functional analyses regarding the identified gene regulating hTERT mRNA.
Results and discussion

Screening of BAC library and transfection into HMc-Li7
We investigated the 3 BAC clones using a sequencetagged-site marker (D10S1728) by PCR, based on previous reports [18, 19] . From these studies, we determined that the 3 BAC clones (M-6, H-11, and J-21) contained D10S1728.
Whole sequencing of H-11 and exon trapping
Approximately 90%~95% of the BAC clone H-11 sequence and supercontig were determined (studies were performed by the University of Colorado Cancer Center Sequencing Core). D10S1728 was regarded as the sequence on 10p15. 3 . We reconfirmed that the sequence and supercontig were derived from the original BAC clones by Southern blotting and PCR, and 20 exons were thereafter identified (fig 1-(a) ). We performed a computer analysis for each contig, and the endosequences of the 3 BAC clones and the exon sequences we trapped showed that they closely overlapped each other (fig 1-(b) ).
Northern blot analysis and one-step real-time RT-PCR Using a probe against each exon sequence (47-376 bp), Northern blotting was performed, which demonstrated that several exons showed a very faint signal (data not shown). In particular, a very faint single hybridization signal in human Multiple Tissue Northern (MTN) blot (Clontech) migrating at about 250 bp was determined for RGM249. One-step real-time RT-PCR showed a very low expression rate, that is, less than 20,000 copies per 50 ng of total RNA extracted from human organs (fig 2-(b) ). In normal liver, approximately 60 copies per 50 ng of total RNA of transcripts were expressed. In contrast, the study on human primary hepatocyte cultures, including nuclear and cytoplasmic compartments in 4 hepatoma cell lines (HepG2, Huh7, HMc-Li7 and Alexander), indicated that hepatoma cells expressed RGM249 at much higher levels than normal human hepatocytes (fig 2-(c) ). In 39 hepatomas, the expression rate was higher (mean ± SEM: 609.2 ± 261.5 copy number per 100 ng/μl) than in the 35 adjacent noncancerous lesions (138.9 ± 46.5) (P = 0.007 by ttest and P = 0.040 by paired t-test) (fig 2-(d) ).
5' & 3' RACE and cDNA library screening 5' and 3' RACE was performed using liver c DNA libraries (Clontech). Screening of the cDNA libraries yielded a clone with a full sequence length of 249 bp. A comparison of the cDNA sequence with the genomic sequence from H-11 revealed that the gene of interest was extended across 9 kb. The cDNA named RGM249 consisted of 2 exons and the RNA was not polyadenylated (fig 1-(b) ). The sequence with about 40% of the GC ratio is shown in fig 3-(a) , indicating that this gene might be a noncoding RNA (ncRNA) gene, as shown in fig 3-(b) . PCR-Single Strand Conformation Polymorphism (PCR-SSCP) and sequencing showed that the gene had no mutations other than a one-base addition at the last site of exon 1 in 10 normal liver tissue samples (10%; 1/10) and no mutations in 4 tumor cell lines (0%; 0/4). Although the cDNA showed no homology with either additional human loci except for the endogeneous locus, or mouse genome, the miRNA predicted to be digested from RGM249 by Dicer matched at least 3 miRNAs in the miRNA database (miRBase; mature miRNAs or stem-loop sequences) http://microrna.sanger.ac. uk/sequences/search.shtml. Although their functions remain unknown because we have not fully clarified whether RGM249 is actually processed by Dicer in vivo, given that it can be processed by Dicer in vitro. On the other hand, a motif search predicted no motifs in the RGM249 gene. Because this gene generated no protein, the secondary structure of RGM249 was drawn based on the structure provided at http://www.tbi.univie.ac.at/~ivo/RNA/ (fig 3-(b) ). Moreover, because the full-length RNA was digested by Dicer enzymes, 20-23 bp sharp bands could be observed, indicating that nucleotides generated from RGM249 RNA may be miRNAs (fig 3-(c) ).
GeneBank accession number
Sequence data have been deposited with the EMBL/ GenBank Data Libraries under accession no. EF433558. Cancerous lesions showed a significant upregulation of RGM249 mRNA, compared with noncancerous lesions, as determined by the t-test (P = 0.007) and paired t-test (P = 0.040). Box represents 95% confidence intervals.
The effects of downregulating RGM249
In many hTERT-or hTR-regulating molecules reported previously, only two factors, hTERT and ribosomal protein L22 (RPL22), were transcriptionally suppressed in the hepatoma-derived cell lines (HLF) transfected with full-length RGM249 dsRNA (fig 4-(a) ) [31] . To reconfirm the findings in dsRNA method, the siRNA method was performed. Results showed that their expressions were suppressed in HLF cells transfected with Stealth siRNA ① (fig 4-(b) ,(c)).
RGM249 siRNA suppressed more than 90% of hTERT mRNA, approximately 50% of RPL22 mRNA, and RGM249 transcripts (fig 4-(c) ) unlike hTR expression. However, RPL22 expression in cells transfected with Stealth siRNA ① was weaker (50%) than in those transfected with full-length dsRNA (fig 4-(c) ). siRNA ① + ② had less efficient knockdown due to the interaction between both siRNAs. These findings are consistent with our results obtained from dsRNA induction, an experiment performed under conditions of almost negligible cytokine storm. A similar result was obtained about 48 hours after transfection.
Subsequently, we examined the inhibitory effect of shRNA transfection. Compared with LacZ shRNA, we found that RGM249 shRNA and mt-1RGM249 shRNA Table 2 . (c) Quantitative evaluation of the suppressive effect of siRNA in which the measurement, in the case without siRNA, was regarded as 100% for standardization (N = 5), suggesting that siRNA ① has a functional sequence. RGM249 siRNA transcriptionally suppressed more than 80% of hTERT expression and approximately 50% of RPL22 expression. RGM249 mRNA, ▯ hTERT mRNA, RPL22 mRNA. d) Quantitative evaluation of the inhibitory effect of RGM249 shRNA on RGM249 mRNA, hTERT mRNA, and RPL22 mRNA. From left, transfection using only transfection reagents, LacZ shRNA as the gene control, wtRGM249 shRNA, and mt-1RGM249 or mt-2RGM249 shRNA with a different mutation (a nucleotide T or C) in the functional sequence. A total of 5 transfections were performed and data were statistically analyzed using the Mann-Whitney test. Compared with LacZ shRNA, RGM249 and mt-1RGM249 shRNA significantly suppressed hTERT mRNA (P = 0.002 and P = 0.034, respectively). mt-1RGM249 and mt-2RGM249 correspond to those in Table 2 . ▯ RGM249 mRNA, hTERT mRNA, RPL22 mRNA, *: P < 0.05; **: P < 0.01. Quantitative evaluation of the suppressive effect of shRNA in which the measurement, in the case without siRNA, was regarded as 100% for standardization (N = 5). (e) Telomerase activity was quantitatively compared using image analyzer between transfectants with LacZ shRNA (in proliferative state) and RGM249 shRNA (in senesced state) and RGM249 shRNA, and was compared with the parental cells (112 and 54, respectively, which had an intensity of 100). Although the results depended on the timing of cell harvests after transfection, telomerase activity in transfectants with RGM249 shRNA was reduced to approximately half compared with that in parental cells, and we observed a periodicity of 6 bp due to reduced telomerase in the shRNA lane. NC: telomerase negative control. significantly downregulated hTERT mRNA (P = 0.002 and P = 0.034, respectively, using the Mann-Whitney test; fig 4-(d) ). Otherwise, no significant differences were observed, except for the effect on RGM249 mRNA. Similar to transfectants that received RGM249 siRNA, telomerase activity in transfectants with shRNA was suppressed in the same manner as mRNA expression, compared with that in transfectants with LacZ shRNA (fig 4-(e) ). Telomere length was not measured due to the small number of cells available and the relatively short observation period. No immunoreactive effects on tumor cell proliferation resulting from cytokine storm were recognized in the GE profile by microarray analysis, which resulted in IFN-β being downregulated twofold.
The effects of overexpressing RGM249 mRNA In the transfection of HLF or A172 cells showing RGM249 overexpression, as distinct from the transfection of other cell lines such as senescing or welldifferentiated cells, hTERT mRNA was significantly downregulated. In particular, the growth of A172 transfectants was strongly suppressed and they were induced to undergo senescence. On the other hand, hTERT mRNA was upregulated in KMST cells, which was established by exposure to chemical oncogens (Additional file 1). However, the expression of hTR, β-actin, and RPL22 mRNA showed no significant differences between mock transfectants and RGM249 transfectants in KMST cells, similar to the transcriptional level of c-Myc, undifferentiated markers (Rex-1 and GATA4), and an initiation factor (eIF6). Additionally, the longevity and proliferation rate of transfectants were almost the same as those of the parental cells or mock transfectants. Interestingly, we examined the effect of RGM249 shRNA wrapped by cationized carriers on tumorigenesis in nude mice using local or venous injection, which resulted in more than 60% of the suppressive effect in vivo (manuscript in preparation). FACS analysis showed that RGM249 mRNA expression introduced more than half of RGM249 pRNAT/U6.1/neo/GFP-transfected populations into the preG1 phase ( fig 5-(a) ), senescence, and apoptosis ( fig 5-(b) ), compared with pRNAT/U6.1/neo/ GFP-transfectants. These phenotypic changes were similar to the effects of RGM249 shRNA, compared with those of LacZ shRNA LOH in human hepatocellular carcinoma (HCC) is rare, except at 10q26.11-qter, which is observed in 25% of HCC cases (32) . However, relatively frequent alterations and deletions of chromosome 10p have been identified in human tumors, including glioblastoma multiforme (GBM) and malignant melanoma [33, 34] . In GBM, 3 common distinct regions of chromosome 10 deletion have been frequently identified; one of them is the distal half of the short arm [15, 35] , indicating that several distinct tumor suppressor genes may be present on chromosome 10 and may contribute to the progression of malignant tumors. Structural alterations have only been observed in malignant melanoma (10p13-pter), gastric cancer (10p15), and GBM (10p14-pter). Unexpectedly, RGM249 with low GC ratio on 10p15.3 is potently miRNAs-generating gene, as well as cancerrelated gene.
It is well known that a miRNA, generated from a miRNA precursor gene, can act as a new regulator which induces cancer cell lines to adopt a suppressive phenotype, except for the tumor suppressor gene. Because the phenotype we observed in a series of transfections with a chromosome (fragment) or BAC was suppressed, this miRNA might be a Suppressor-miR or it might have demonstrated a miRNA-directed inhibition. Actually, RGM249 repressed hTERT mRNA in A172 cells derived from GBM, moderately differentiated HCC (HMc-Li7), and poorly differentiated HLF. Beyond 60S RPL22, which we referred to in this study, several ribosomal protein mRNAs changed their expression level after the introduction of siRNA or shRNA into cell lines or tumors inoculated in nude mice (data not shown). In a miRNAmediated mRNA repression study, RPL22, of which Greider et al. previously referred to as one of the binding protein to hTR that is essentially required for telomere maintenance and telomerase activity in normal tissues and disease, showed no significant alteration in expression level, whereas it showed an obvious change in siRNA-directed RNAi with reproducibility (2.08-fold downregulation in microarray analysis) [31] . We do not have any definite evidence that RPL22 functions in association with hTERT expression during carcinogenesis or in hypoxic tissues. However, while endogenous hTR expression is regulated at the transcriptional level, hTERT is regulated by alternative splicing under hypoxic conditions [36] . It may be that RPL22 influences hTERT expression through hTR expression. RGM249 dsRNA repressed RPL22. However, RGM249 siRNA and shRNA did not significantly repress RPL22 because of the high homology shared by 2 parts of the RGM249 sequence which are different from the functional sequence, which was used in siRNA or shRNA and corresponds to one part of the RPL22 sequence. Eukaryotic initiation factor 6 (eIF6) has long been known to bind to free 60S ribosomal subunits, preventing the assembly of translationally competent 80S ribosome particles [37] . Similar to eIF4E bound to Argonaute2 (Ago2), which regulates mRNA expression by cleaving its mRNA targets and competing with eIF6 for the mRNA cap [38] , eIF6 may mediate siRNA-directed RNA interference rather than miRNA-directed translational repression. This study indicates that the sequence focused for siRNA or
shRNA has a key function in this gene, and that RGM249 may functionally have a close link to gene-mediated processes at the transcriptional level, such as RNA biogenesis or gene regulation, and a link to ribonucleoproteins such as telomerase or RPL22. As a result, RNA molecules may induce suppressive or apoptotic events in cancer cells through an RGM249-related signaling pathway involved in a DNA-, RNA-, or protein-binding function (some of the significantly changed genes are shown in fig 6; there were 306 upregulated genes and 144 downregulated genes in the in vitro trial) miRNA is physiologically generated by both Drosha and Dicer. We can not digest RGM249 mRNA by Drosha because Drosha protein is now unavailable commercially. RGM249 RNA processed by DICER, results in at least 3 small fragments of a product (17-23 bp) related to RNA species (fig 3-(c) ). The sequencing of diced RGM249 mRNA proved that the sequence we used for siRNA or shRNA was included in fig 3-(b) . Because the silencing of RGM249 induced the downregulation of hTERT expression, this gene may be involved in the oncogenic mechanism. In humans,~800 miRNAs are predicted to exist [39] ; each of these is thought to have hundreds of targets, suggesting that miRNAs play a critical regulatory role in cellular protein expression [40] . In various human cancers as well as in developmental timing and patterning, differentiation, organogenesis, and stress response, alterations of miRNA profiles have been observed; these miRNAs may act as oncogenes, leading to the specific dysregulation of their target gene transcripts [41, 42] . Although alterations in miRNA expression have been described in cancer and may contribute to other disease states, it remains unclear what drives these alterations. Our findings might pave the way for defining unknown crucial roles that miRNAs located around this locus play in oncogenic regulation through hTERT regulation and, in particular, the role RGM249 may play during this process.
Although the way in which RGM249 regulates hTERT remains unidentified, the physiological expression of RGM249 synchronizes the upregulation of hTERT mRNA, and its excess expression using the RNA-expression vector downregulated hTERT in specific cancer cells. Moreover, its siRNA or shRNA suppressed hTERT. Taken together, RGM249 may function negatively or positively, reversibly or indirectly on unknown mediators upstream of hTERT. Using microarray analysis between transfectants with RGM249 siRNA and those with LacZ siRNA (fig 6) , the comparative expression analysis demonstrated that ATM and TP53LP were upregulated, although p53 status (the presence of mutation) in each cell line did not correlate with hTERT mRNA expression, and Ras and several transcriptional factors were downregulated. As described in fig 6, RGM249 may have direct Figure 6 A representative gene expression in microarray analysis. Representatives of regulated genes using microarray analysis performed between transfectants with LacZ shRNA and RGM249 shRNA are shown as a gene symbol (description) and ×fold. Following transfection of the RNA generating-vector and presumably the generation of RNA molecules, many transcriptional factors, the molecules involved in RNA biogenesis, and tumor-related genes altered the expression level. This novel noncoding gene is strongly expressed in poorly differentiated tumor cells. The genes (mRNAs) targeted commonly by both miRNAs and siRNAs in our study were MAPK6 and PRKCA, which can induce hTERT upregulation ( fig 7-(a) ). Representative genes (mRNAs) targeted by miRNAs with expression upregulated more than twofold by shRGM249RNA included DICER1, high mobility group A2 (HMGA2) and GAS7, as well as hsa-miR-let 7b, 7d, 7e, 7f, and 7g targets. In particular, RGM249 might be implicated in oncogenic transformation through the inhibition of HMGA2 interacting with let-7 miRNA (fig 7-(b) , (c)) [43] . RGM249 was not detected in any 'mirtrons or polycistron' detection program, genome, or miRNA database (MiRscan, PicTar, miRanda, etc.) [44] . We are now considering MED18 as a key molecule obtained from microarray analysis (fig 6 and 7) [46] . A mediator complex is essential for transcription induced by pol II in eukaryotes and is required for the recruitment of the transcription machinery after chromatin remodeling [47] . MED18 may also be involved in the repression of differentiation, transcription, and telomere elongation. Microarray analysis revealed a strong upregulation of MED18 (×24.8), the RNA polymerase II mediator which functions as a coactivator involved in transcription regulation in nearly all RNA polymerase IIdependent genes, and other RNA-related or DNA-binding genes were upregulated (fig 6) . In transfectants with MED18 siRNA, both RGM249 and hTERT mRNA were significantly upregulated (Supplement fig 2-(d) ). MED18 siRNA transfected into A172 cells significantly upregulated hTERT mRNA and RGM249 expression (Additional file 1-(d) ). Co-transfection by both MED18 siRNA and hTERT siRNA upregulated only RGM249 mRNA, suggesting that RGM249 may functionally locate upstream hTERT mRNA, and MED18 may closely interact with RGM249. Overexpressing RGM249 is carried out for the purpose of comprehending the possible suppressive effects of miRNAs and depleting RGM249 is performed for the purpose of understanding the physiological function of this gene. Our results suggest that RGM249 may not be a precursor gene such as Onco-miR but is a Suppressor-miR and might function to lower differentiation in its expressing cells by suppressing cell growth as an independent response to hTERT expression.
Conclusion
Taken together, the enhanced cell death in RGM249 transfectants likely resulted from an hTERT-independent mechanism or the presence of a mediator with crucial responsibility for oncogenesis, arguing that some other targets instead of hTERT might be the real players mediating these contradictory oncogenic and growth suppressive functions. It should be noted that mRNA studies do not always reflect processes at the protein level of gene regulation.
Further studies will be required to investigate these expression levels. Several ncRNAs in the exons we trapped might provide new insights into the coordinated and dynamic mechanisms of development, stress, transformation, and (de)differentiation, resulting in the possible prevention of oncogenesis and suppression of tumor progression.
Methods
DNA preparation and analysis BAC clones (H-11, M-6, and J-21) were selected on the basis of results from a previous experiment (Research Genetics, Toronto, Canada) [18] . BAC DNA was isolated using a modified alkaline lysis protocol [18] . Pulsed-field electrophoresis analysis of the isolated BAC DNA was performed using the CHEF DRII system (Bio-Rad, CA, USA).
Sequence determination and analysis, and construction of a contig of BAC clones (M-6, H-11, and J-21) Purified BAC DNAs were shared using the AERO-MIST nebulizer (CIS-US, Bedford, MA, USA) and after ligation of adapters, these DNAs were subcloned into the BstXI sites of pSHOT II, which was constructed by subcloning the BstXI sites from pcDNA II, prior to the disclosure of the endosequences of the 3 BAC clones (M-6, H-11, and J-21) (fig 1-(b) ). A sequencing library was generated by sonicating BAC and cloning it into a phosphatased EcoRV site in Bluescript; initially, each clone was sequenced using Phil Greene's Phred and Phrap programs.
Exon trapping
For all exon trapping experiments, we used the exontrapping system kit (Gibco-BRL, Gaithersburg MD, USA) and the supplements recommended therein. We RAD51 like 3  MAPK2K4  H3 histone 3B  DYRK1A  DYRK3  RB1  RAB2A  GPR22  GPR23  ZEB2  LARP4  CTNNBIP1  BLCAP   hsa_miR_196a   GAS7  HOXA5, A7, A9  HOXB7, C8  GATA6  LARP4  NRAS  HMGA2  DICER1  MAPK4K3  P27/ A representative miRNA expression in microRNAarray analysis and predictive target genes. (a) Representative genes predicted to be commonly targeted by RGM249 miRNAs or siRNAs are shown. 4 miRNAs were predicted from the RGM249 sequence by miRBase http://microrna.sanger.ac.uk/sequences/index.shtml or miRNAMAP http://mirnamap.mbc.nctu. edu.tw/html/search.html and it was predicted that the miRNAs might inhibit the translation of genes involved in oxidation and RAS activation. As reported previously in association with hTERT expression, PRKCA, MAPK1, and AKT1 were included in the targeted genes. (b) Seven miRNAs upregulated more than twofold in RGM249 shRNA-transfectants by microRNAarray analysis performed between transfectants with LacZ shRNA and RGM249 shRNA are shown. Some of these 7 miRNAs have been indicated in the oncogenesis of oral squamous cell carcinoma (unpublished data). (c) Representative genes targeted by miRNAs which changed more than twofold when induced by shRGM249RNA are shown. The genes were predicted mainly using miRNAMAP. Three miRNAs were presumably targeted towards miRNA processing proteins, transcriptional factors, telomere-related genes, TERT-related genes, tumor suppressor-related genes, and cell cycle-related genes. shotgunned M-6, H-11, and J-21 into pSPL3, employing BamHI and BglII or BamHI, BglII, and PstI for 2 ways of cutting BAC DNA using restriction enzymes. This method was performed as described previously [21] . Thereafter, the BAC whole sequence or cDNA sequence was identified using a database http://www.ncbi.nlm. nih.gov/. In 1999 to 2005, the sequenced reference human genome draft was not definitely determined on 10p14-15 and altered several times during this interval.
Northern blotting, reverse-transcriptase polymerase chain reaction (RT-PCR), and onestep real-time RT-PCR for confirming the expression of exons in human organs The probe, consisting of the respective exons, including two exons forming RGM249, radiolabeled by random priming using the Radprime kit (Gibco-BRL), was incubated with human multiple tissue northern blot (Human 12-Lane MTN Blot) (Clontech, Mountain View, CA, USA). One-step real-time RT-PCR experiments were performed using Human Total RNA Master Panels (Clontech) according to methods we previously reported using LightCycler (Roche, Basel, Switzerland) [48] . The primer sequences used are shown in Table 1 . Each quantification was confirmed by sequencing with high reproducibility (for RGM249; fig 2-(a) , r = 0.998, for hTERT) [48] .
cDNA cloning and exon/intron organization Using the exons identified by Northern blotting or RT-PCR, we amplified cDNA fragments from human skeletal muscle and liver "Marathon-ready" cDNA, according to the manufacturer's protocol (Clontech). Amplicons were subcloned into the pcDNA3 vector (Invitrogen, Leek, The Netherlands). A comparison of cDNA and genomic sequences revealed a total of 20 exons and detected 3 alternative splice donor sites for 6 exons.
PCR-single-strand conformation polymorphism (SSCP) analysis for the detection of mutations in exons
To screen for point mutations in trapped exons, we performed PCR-SSCP assays using flanking intron primers, as previously described [49] .
Measurement of telomerase activity
To confirm telomerase activity in transfectants after siRNA transfection, a telomerase detection kit, TRAP-eze, (Oncor Inc., Gaithersburg, MD, USA) used for RGM249 cloning and the TeloChaser kit (TOYOBO, Osaka, Japan) used for the expression analysis of shRNA transfectants, were employed for the telomeric repeat amplification protocol assay according to the manufacturer's protocol. Quantification of TRAP was estimated using an image analyzer (CS Analyzer 3) provided by ATTO Corp. (Tokyo, Japan).
Structural prediction of RGM249
To examine whether RGM249 can generate a protein, we performed an in vitro translation assay according to the manufacturer's instructions (Clontech). After examining the motif and homology http://www.ncbi.nlm.nih.gov/ genome/seq/BlastGen/BlastGen.cgi?taxid=9606; http:// hmmpfam.ddbj.nig.ac.jp/; http://blast.ncbi.nlm.nih. gov/Blast.cgi), we predicted the secondary structure of RGM249 using the Vienna RNA Secondary prediction and comparison program http://www.tbi.univie.ac.at/ ivo/RNA/; http://www.genebee.msu.su/services/rna2_r-educed.html). Subsequently, we screened the micro RNA) (miRNA) database among species. To confirm whether the RGM249 gene functions as a miRNA precursor gene, we digested the full-length RNA with a Dicer enzyme using a Dicer siRNA generation kit according to the manufacturer's protocol (Gene Therapy Systems, Inc., CA, USA).
RGM249 mRNA expression in human organs, hepatocytes, hepatoma cell lines, and liver tissues To confirm the transcriptional level (copy number) in human organs, liver-related normal cells, and immortalized cells, we performed one-step real-time RT-PCR using human hepatocytes (KAC, Kyoto, Japan), hepatoma cell lines (Tohoku University, Sendai, Japan), and 74 surgically resected liver tissue samples, including 33 pairs of hepatomas and corresponding adjacent tissues. Transfection of total dsRNA and gene-specific siRNA derived from the RGM249 gene dsRNA derived from the RGM249 sequence was generated from the expression vector with RGM249 in the MCS of Litmas28i (NEB, MA, USA) using an in vitro transcription method (T7 RiboMAX Express Large Scale RNA Production System, Promega, Madison, WI, USA) and was transfected into 4 hepatoma cell lines (HLF, Alexander, HepG2, and HMc-Li7) at a concentration range of 10-40 μg/ml medium. Subsequently, to avoid unspecific inhibition of dsRNA through interferon (INF) activation [50, 24] , stealth siRNAs were designed on-line using RNAi designer provided by Invitrogen (Tokyo, Japan). At the optimal concentration (25 nM) of siRNA to the recipient (HLF), which expresses it strongly, we repeatedly performed transfections to examine the correlation of telomerase-related factors (hTR, TEP1, dyskerin, RPL22, etc.) with RGM249 expression [31] . The expression of telomerase-related genes was estimated by RT-PCR after transfection of dsRNA (fig 4-(a) ).
siRNA method Two kinds of siRNAs (siRNA ① and siRNA ②) were designed using the Stealth RNAi designer and synthesized by Invitrogen (Invitrogen Corp, Carlsbad, CA, USA). The sequences are shown in Table 2 . To suppress RGM249 expression with siRNA, we performed the following transfection procedures in HLF cells: transfection using Stealth siRNA ①, transfection employing Stealth siRNA ②, and transfection with both Stealth siRNA ① and Stealth siRNA ② at a final concentration of 25 nM as an optimal condition. We collected transfectants 24 hours after transfection for RNA extraction and confirmed the inhibitory effect on RGM249 expression by one-step RT-PCR. HLF cells treated with FuGene Reagent without siRNAs and with Stealth LacZ siRNA were used as controls. Transfectants were collected 48 hours, 1 week, and 2 weeks after transfection. Subsequently, we confirmed the suppressive effect of shRNA with the same functional sequence as that of siRNA on RGM249 expression, using the BLOCK-iT RNAi Expressing vector (Invitrogen) which was designed to generate shRNA in transfectants. To examine the effect on hTERT expression 7 to 10 days later after selection with 200 μg/ml Zeocin, an shRNA-generating lentiviral vector with the functional sequence of RGM249 (fig 3-(b) ) was transfected. Since the mock of the lentiviral vector was linearized according to the manufacturer's instructions, we used transfection reagents without RNA and the vector, LacZ shRNA as the controls, and wtRGM249 or mtRGM249 (mt-1 or mt-2) with one base (T or C) deletion in the wtRGM249 sequence. We evaluated GE in the transfectants semiquantitatively. Stealth siRNA and shRNA sequences for RGM249 are shown in Table 2 .
Gene expression profile by microarray analysis Microarray analysis was performed for total RNA purified from transfectants with LacZ shRNA and from those with RGM249 shRNA following confirmation of the downregulation of both RGM249 and hTERT mRNA expression by RT-PCR after strict quality control in accordance with the guidelines of the Hokkaido System Science (Sapporo, Japan). Data for genes that had changed more than twofold were additionally analyzed using Gene Ontology Tree Genes targeted by miRNAs were investigated using DIANA-microT, Pictar, TargetScan, and miRanda http://diana.pcbi.upenn.edu/cgi-bin/TargetCombo.cgi.
Abbreviations hTR: telomerase RNA component; BAC: Bacterial artificial chromosome; hTERT: human telomerase reverse transcriptase; siRNA: short interfering RNA; shRNA: short hairpin RNA; RPL22: ribosomal protein L22; ncRNA: noncoding RNA; GE: gene expression.
